TP53 and hepatoblastoma: Importantly, experiments conducted in HepG2 (hepatoblastoma) and HeLa (cervical cancer) cells – both carrying wild-type p53 – showed strong increases in caspase-3/7 activation following combined treatment with lovastatin and docetaxel (Supplementary Figure 2).